US Patent Issued to CYTOMX THERAPEUTICS on June 2 for "Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,951, issued on June 2, was assigned to CYTOMX THERAPEUTICS INC. (South San Francisco, Calif.).

"Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof" was invented by Olga Vasiljeva (Freemont, Calif.) and Michael B. Winter (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates generally to cleavable polypeptides, method of producing a cleavable moiety (CM) containing polypeptide by culturing a cell under conditions that lead to expression of the polypeptide, methods of manufacturing a cleavable moiety (CM) containing polypeptide by culturing a cell comprising a nu...